$0.2350
-0.00300-1.26%
At close: -
$0.2380
0.003001.28%
After Hours: 7:59 PM EDT
Comments
Loading...
Cellectar Biosciences (CLRB) Forecast
NewsEarningsCellectar Biosciences (CLRB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCellectar Biosciences (NASDAQ:CLRB) Stock Quotes, Forecast and News Summary
Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cellectar Biosciences (CLRB) stock?
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Who are Cellectar Biosciences (CLRB) competitors?
Other companies in Cellectar Biosciences’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Addex Therapeutics (NASDAQ:ADXN) and T2 Biosystems (NASDAQ:TTOO).
What is the forecast, or price target, for Cellectar Biosciences (CLRB) stock?
Cellectar Biosciences has a consensus price target of $16.00.
What is the current price for Cellectar Biosciences (CLRB)?
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $0.238 last updated December 20, 2024 at 7:59 PM EST.
Does Cellectar Biosciences (CLRB) pay a dividend?
There are no upcoming dividends for Cellectar Biosciences.
When is Cellectar Biosciences (NASDAQ:CLRB) reporting earnings?
Cellectar Biosciences’s Q3 earnings are confirmed for Monday, November 18, 2024.
Is Cellectar Biosciences (CLRB) going to split?
There is no upcoming split for Cellectar Biosciences.
What sector and industry does Cellectar Biosciences (CLRB) operate in?
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.